Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D

BACKGROUND: Latent Autoimmune Diabetes in Adults (LADA) constitutes around 10% of all diabetes. Many LADA patients gradually lose their insulin secretion and progress to insulin dependency. In a recent trial BALAD (Behandling Av LADa) early insulin treatment compared with sitagliptin failed to prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Björklund, Anneli, Hals, Ingrid K., Grill, Valdemar, Ludvigsson, Johnny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339700/
https://www.ncbi.nlm.nih.gov/pubmed/35923626
http://dx.doi.org/10.3389/fendo.2022.926021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339700/
https://www.ncbi.nlm.nih.gov/pubmed/35923626
http://dx.doi.org/10.3389/fendo.2022.926021

Ejemplares similares